![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, December 14, 2018 12:59:08 PM
If anyone has been here as long as I have (9 years), you have seen like I have, so many mistakes made by this management and leadership. Going on the 'cheap' when dealing with USA FDA has caused delays and been the opposite of cheap. It is costing more in the long run. I had hope, when our CEO FINALLY hired a sales professional, as he was now staffing for what he is NOT qualified to do. Let's hope this new hire is one that IS qualified to seek success in all those countries we are sitting idle in.
Investor sentiment is not good after this latest news from USA FDA and I could only hope our CEO feels the heat. No more pacifying the loyal investors. Need results. Pacifying without results has resulted in triple zero stock price. And THAT {stock price) is our measure on management and CEO success. Hard to believe that he would have survived this long on any reputable established company with these results. Also hard to stay positive as we are hit with bad news over and over again with this attempt at marketing of products in USA.
Well, I might as well buy some more down in here the trips to lower my average, for the possibility that somehow by chance, this management can FINALLY figure out HOW to sell these very effective products.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM